Clinical research of rhGH on pregnancy rate of polycysticovary syndrome
10.3760/cma.j.issn.1008-6315.2013.08.003
- VernacularTitle:重组人生长激素对提高多囊卵巢综合征患者妊娠率的临床研究
- Author:
Yanfang HE
;
Ping LIU
;
Suxin HAN
;
Zhenwei ZUO
- Publication Type:Journal Article
- Keywords:
Polycysticovary syndrome;
Growth hormone;
Pregnancy
- From:Clinical Medicine of China
2013;29(8):790-792
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of recombinant human growth hormone (rhGH) action on pregnancy rate of polycystic ovarian syndrome(PCOS).Methods The PCOS who were client in our hospital in February-August,2012 were investigated.The rhGH group (41 cases) were that all patients took rhGH at the same time ovulation.The control group (41 cases) were no medication group.The two groups had sex action after ovulation.Ovulation rate,pregnancy rate and endometrial score of the two groups were compared.Results Ovulation rate of rhGH group was 90.2％ (37/41),the control group was 68.2％ (28/41),the difference was statistically significant (x2 =3.459,P =0.036).Clinical pregnancy rate of RhGH group was 32.7％ (12/37),the control group was 25.0％ (7/28).The difference was statistics significance (x2 =4.319,P =0.032).Endometrial score of rhGH group was (14.96 ± 2.18),the control group was (12.77 ± 2.60) points,the difference between groups was statistically significant (t =-3.356,P =0.032).Conclusion Giving rhGH ovulation cycle specification can promote ovulation PCOS patients and improve the adverse factors affecting pregnancy,improving the pregnancy rate.
